Sponsors, sites and regulators continue to feel the disruptive effects of the COVID-19 crisis and are scrambling to find solutions, leading to trial delays and enrollment suspensions. Read More
Patient centricity is truly coming to the forefront as sponsors and investigators search for ways to battle the effects of COVID-19 and keep their trials afloat while protecting their participants’ health and safety. Read More
Sponsors and sites must reassess the risks of all their ongoing trials in the face of the COVID-19 pandemic, looking for factors that may increase the severity of already-identified risks and new, unanticipated risks presented by the virus. Read More
WCG Clinical hosted a widely listened-to webinar last week to discuss the impact of COVID-19 on trials. The questions and answers are edited excerpts… Read More
RSS
